Stock listing
OMER Stock Price, News, Filings & Events — Omeros Corporation
Selected listing: OMER · NASDAQ · USD · US
This page tracks Omeros Corporation's OMER:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OMER:NASDAQ. OMER:NASDAQ is the stock-level entry point for investors researching Omeros Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Omeros Corporation is a public company traded under the ticker OMER in the American market. The company has a market capitalization of approximately $708.6 million. Omeros focuses on developing and commercializing innovative therapeutics to address unmet medical needs.
- Ticker
- OMER:NASDAQ
- Asset type
- Stock
- Market cap
- $1.39B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Omeros Corporation OMER:NASDAQ stock context
This page tracks Omeros Corporation's OMER:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OMER:NASDAQ. OMER:NASDAQ is the stock-level entry point for investors researching Omeros Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Omeros Corporation is a public company traded under the ticker OMER in the American market. The company has a market capitalization of approximately $708.6 million. Omeros focuses on developing and commercializing innovative therapeutics to address unmet medical needs.
Latest news from Omeros Corporation
Omeros Corporation Reports Second Quarter 2026 Financial Results
August 12, 2026
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
August 10, 2026
CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
August 3, 2026
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
June 26, 2026
Omeros Corporation Reports First Quarter 2026 Financial Results
May 13, 2026
Omeros Corporation earnings calls
Omeros Corporation (OMER) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Omeros Corporation (OMER) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Omeros Corporation (OMER) Q4 2025 Earnings Call
March 31, 2026 · Replay with transcript and chapters
Omeros Corporation (OMER) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Omeros Corporation (OMER) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Omeros Corporation (OMER) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Omeros Corporation
Omeros Corporation investor report
Review AI stock analysis and investor report context for OMER:NASDAQ.
Omeros Corporation company profile
View the public company page for Omeros Corporation on 6ix.
Omeros Corporation news
Read company news and market updates connected to Omeros Corporation.
Omeros Corporation investor events
Find investor webinars, events, and replay context for Omeros Corporation.
Alternate listings
3O8:GETTEX
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
OMER:BOATS
US · USD
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
A0NBFF:LS
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
A0NBFF:LSX
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
0KBU:LSE
GB · USD
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:FWB
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:TRADEGATE
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:BX
CH · CHF
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:DUS
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:HAM
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:MUN
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.
3O8:SWB
DE · EUR
Alternate listing for Omeros Corporation; the primary context on this page is OMER:NASDAQ.